---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-24-000132"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:18:36.828531+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners Q2 revenue +14.2% to $762.1M; raises FY2024 guidance

## Summary
- Revenue $762.1M (+14.2% YoY); same-facility revenue up 9.9%, cases up 3.9%.
- Adjusted EBITDA $118.3M (+18.1%); margin 15.5% (+50 bps).
- Net loss attributable to company $15.5M.
- FY2024 guidance raised: revenue >$3.075B, Adjusted EBITDA >$508M.
- Deployed ~$220M on acquisitions YTD; balance sheet refinanced and hedged.

## SEC filing metadata
- accession: 0001638833-24-000132
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883324000132/0001638833-24-000132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883324000132/sgry-20240806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-24-000132
- JSON: https://secwatch.observer/filing/0001638833-24-000132.json
- Plain text: https://secwatch.observer/filing/0001638833-24-000132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.